Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series-Reference-Cited by-同舟云学术

Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series

Published:2023-03 Issue:3 Volume:29 Page:393-395
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Hoellinger Baptiste,Simand Célestine,Jeannot Katy,Garijo Carlos,Cristinar Mircea,Reisz Fanny,Danion François,Ursenbach Axel,Lefebvre Nicolas,Boyer Pierre,Hansmann Yves,Studer Antoine,Schramm Frédéric,Ruch Yvon

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. EUCAST breakpoint tables for interpretation of MICs and zone diameters,2022

2. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales;Bonnin;Clin Microbiol Infect,2022

3. Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections;Meschiari;JAC Antimicrob Resist,2021

4. A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol

5. Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance;Karakonstantis;Antibiotics (Basel),2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria;Antibiotics;2024-09-12

2. Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak;Antibiotics;2024-08-15

3. Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice;Current Opinion in Infectious Diseases;2024-07-30

4. Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study;Infectious Diseases and Therapy;2024-07-12

5. Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues;Heliyon;2024-05